Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 117, Issue , 2014, Pages 303-311

  Kalhapure, Rahul S ^a   Mocktar, Chunderika ^a   Sikwal, Dhiraj R ^a   Sonawane, Sandeep J ^a   Kathiravan, Muthu K ^a   Skelton, Adam ^a   Govender, Thirumala ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Encapsulation efficiency; Ion pairing; Linoleic acid; Methicillin resistant Staphylococcus aureus (MRSA); Solid lipid nanoparticles; Vancomycin

Indexed keywords

ENCAPSULATION EFFICIENCY; ION PAIRING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOLID LIPID NANOPARTICLE (SLN); VANCOMYCIN;

BACTERIA; BINDING ENERGY; ENCAPSULATION; HOMOGENIZATION METHOD; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY;

LINOLEIC ACID;

LINOLEIC ACID; SOLID LIPID NANOPARTICLE; VANCOMYCIN; ANTIINFECTIVE AGENT; ION; LIPID; NANOPARTICLE; SURFACTANT;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR MODEL; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; STATIC ELECTRICITY; TIME; ULTRASOUND; ULTRASTRUCTURE;

ANTI-BACTERIAL AGENTS; IONS; LINOLEIC ACID; LIPIDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; NANOPARTICLES; PARTICLE SIZE; SONICATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; SURFACE-ACTIVE AGENTS; TIME FACTORS; VANCOMYCIN;

EID: 84897892999     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.02.045     Document Type: Article

References (59)

1. (accessed 23.09.13). http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part4.pdf.
2. Huh A.J., Kwon Y.J. J. Control. Release 2011, 156:128-145.
3. Hajipour M.J., Fromm K.M., AkbarAshkarran A., Jimenez de Aberasturi D., Larramendi I.R.d., Rojo T., Serpooshan V., Parak W.J., Mahmoudi M. Trends Biotechnol. 2012, 30:499-511.
4. Cohen M.L. Nature 2000, 406:762-767.
5. Gold H.S., Moellering R.C. N. Engl. J. Med. 1996, 335:1445-1453.
6. Périchon B., Courvalin P. Antimicrob. Agents Chemother. 2009, 53:4580-4587.
7. Walsh C.T. Curr. Opin. Microbiol. 2005, 8:495-497.
8. (accessed 13.09.13). http://www.idsociety.org/10x20/.
9. Kataria B.C., Mehta D.S., Mehta S.J. Int. J. Antimicrob. Agents 2012, 40:85-86.
10. Beaulac C., Clement-Major S., Hawari J., Lagacé J. Antimicrob. Agents Chemother. 1996, 40:665-669.
11. Blecher K., Nasir A., Friedman A. Virulence 2011, 2:395-401.
12. Zhang L., Pornpattananangkul D., Hu C.-M., Huang C.-M. Curr. Med. Chem. 2010, 17:585-594.
13. Pelgrift R.Y., Pelgrift A.J., Friedman A.J. Adv. Drug Deliv. Rev. 2013, 65:1803-1815.
14. Schairer D.O., Chouake J.S., Nosanchuk J.D., Friedman A.J. Virulence 2012, 3:271-279.
15. Knetsch M.L., Koole L.H. Polymers 2011, 3:340-366.
16. Friedman A.J., Phan J., Schairer D.O., Champer J., Qin M., Pirouz A., Blecher-Paz K., Oren A., Liu P.T., Modlin R.L. J. Invest. Dermatol. 2013, 133:1231-1239.
17. Mehnert W., Mäder K. Adv. Drug Deliv. Rev. 2001, 47:165-196.
18. Gasco M.R. Adv. Drug Deliv. Rev. 2007, 59:377-378.
19. Kheradmandnia S., Vasheghani-Farahani E., Nosrati M., Atyabi F. Nanomed. Nanotechnol. Biol. Med. 2010, 6:753-759.
20. Varshosaz J., Minayian M., Moazen E. J. Liposome Res. 2010, 20:115-123.
21. Date A.A., Joshi M.D., Patravale V.B. Adv. Drug Deliv. Rev. 2007, 59:505-521.
22. Muller R.H., Keck C.M. J. Biotechnol. 2004, 113:151-170.
23. zur Mühlen A., Schwarz C., Mehnert W. Eur. J. Pharm. Biopharm. 1998, 45:149-155.
24. Müller R.H., Mäder K., Gohla S. Eur. J. Pharm. Biopharm. 2000, 50:161-177.
25. Souto E., Müller R. J. Microencapsul. 2005, 22:501-510.
26. Tan S.W., Billa N., Roberts C.R., Burley J.C. Colloids Surf. A 2010, 372:73-79.
27. Lv Q., Yu A., Xi Y., Li H., Song Z., Cui J., Cao F., Zhai G. Int. J. Pharm. 2009, 372:191-198.
28. Kamiya S., Yamada M., Kurita T., Miyagishima A., Arakawa M., Sonobe T. Int. J. Pharm. 2008, 354:242-247.
29. Zhang Z., Bu H., Gao Z., Huang Y., Gao F., Li Y. Int. J. Pharm. 2010, 394:147-153.
30. Venkateswarlu V., Manjunath K. J. Control. Release 2004, 95:627-638.
31. Xie S., Zhu L., Dong Z., Wang X., Wang Y., Li X., Zhou W. Colloids Surf. B 2011, 83:382-387.
32. Wang Y., Zhu L., Dong Z., Xie S., Chen X., Lu M., Wang X., Li X., Zhou W. Colloids Surf. B 2012, 98:105-111.
33. Wang X.F., Zhang S.L., Zhu L.Y., Xie S.Y., Dong Z., Wang Y., Zhou W.Z. Vet. J. 2012, 191:115-120.
34. Prombutara P., Kulwatthanasal Y., Supaka N., Sramala I., Chareonpornwattana S. Food Control 2012, 24:184-190.
35. Nicolaou K., Hughes R., Cho S.Y., Winssinger N., Labischinski H., Endermann R. Chem. Eur. J. 2001, 7:3824-3843.
36. Saha B., Singh A.K., Ghosh A., Bal M. J. Med. Microbiol. 2008, 57:72-79.
37. Chakraborty S.P., Sahu S.K., Mahapatra S.K., Santra S., Bal M., Roy S., Pramanik P. Nanotechnology 2010, 21:1-9.
38. Wong H.L., Bendayan R., Rauth A.M., Wu X.Y. J. Pharm. Sci. 2004, 93:1993-2008.
39. Zheng C.J., Yoo J.-S., Lee T.-G., Cho H.-Y., Kim Y.-H., Kim W.-G. FEBS Lett. 2005, 579:5157-5162.
40. Desbois A.P., Smith V.J. Appl. Microbiol. Biotechnol. 2010, 85:1629-1642.
41. Smith P.A., Romesberg F.E. Nat. Chem. Biol. 2007, 3:549-556.
42. Hanwell M.D., Curtis D.E., Lonie D.C., Vandermeersch T., Zurek E., Hutchison G.R. J. Cheminform. 2012, 4:1-17.
43. Halgren T.A. J. Comp. Chem. 1996, 17:490-519.
44. Li F.-Q., Hu J.-H., Deng J.-X., Su H., Xu S., Liu J.-Y. Int. J. Pharm. 2006, 324:152-157.
45. Teeranachaideekul V., Souto E.B., Junyaprasert V.B., Müller R.H. Eur. J.Pharm. Biopharm. 2007, 67:141-148.
46. Kabara J.J., Swieczkowski D.M., Conley A.J., Truant J.P. Antimicrob. Agents Chemother. 1972, 2:23-28.
47. Feldlaufer M., Knox D., Lusby W., Shimanuki H. Apidologie 1993, 24:95-99.
48. Greenway D., Dyke K. J. Gen. Microbiol. 1979, 115:233-245.
49. Saito H., Tomioka H., Yoneyama T. Antimicrob. Agents Chemother. 1984, 26:164-169.
50. Knapp H.R., Melly M.A. J. Infect. Dis. 1986, 154:84-94.
51. Song H., Nie S., Yang X., Li N., Xu H., Zheng L., Pan W. Int. J. Nanomed. 2010, 5:933-942.
52. Lim S.-J., Kim C.-K. Int. J. Pharm. 2002, 243:135-146.
53. Wanawongthai C., Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., Yamamoto K. Int. J. Pharm. 2009, 376:169-175.
54. Kalhapure R.S., Akamanchi K.G. Int. J. Pharm. 2012, 425:9-18.
55. Spectrometric Identification of Organic Compounds 2005, 71-143. Wiley, New York. 7th ed. R.M. Silverstein, F.X. Webster, D.J. Kiemle (Eds.).
56. Riddick T.M. Zeta Potential 2007, Zeta-Meter Inc., Staunton.
57. Dörwald F.Z. Lead Optimization for Medicinal Chemists 2012, 361. Wiley, Weinheim.
58. Radovic-Moreno A.F., Lu T.K., Puscasu V.A., Yoon C.J., Langer R., Farokhzad O.C. ACS Nano 2012, 6:4279-4287.
59. Mussi S.V., Silva R.C., Oliveira M.C.d., Lucci C.M., Azevedo R.B.d., Ferreira L.A.M. Eur. J. Pharm. Sci. 2013, 48:282-290.